In 2023, West Virginia had the highest share of adults (**** percent) who had ever been told by a doctor that they had diabetes. This statistic represents the percentage of adults in the United States who had ever been diagnosed diabetes as of 2023, by state.

It was estimated that as of 2023, around **** million people in the United States had been diagnosed with diabetes. The number of people diagnosed with diabetes in the U.S. has increased in recent years and the disease is now a major health issue. Diabetes is now the seventh leading cause of death in the United States, accounting for ******percent of all deaths. What is prediabetes? A person is considered to have prediabetes if their blood sugar levels are higher than normal but not high enough to be diagnosed with type 2 diabetes. As of 2021, it was estimated that around ** million men and ** million women in the United States had prediabetes. However, according to the CDC, around ** percent of these people do not know they have this condition. Not only does prediabetes increase the risk of developing type 2 diabetes, but also increases the risk of heart disease and stroke. The states with the highest share of adults who had ever been told they have prediabetes are California, Hawaii, and New Mexico. The prevalence of diabetes in the United States As of 2023, around *** percent of adults in the United States had been diagnosed with diabetes, an increase from ****percent in the year 2000. Diabetes is much more common among older adults, with around ** percent of those aged 60 years and older diagnosed with diabetes, compared to just ****percent of those aged 20 to 39 years. The states with the highest prevalence of diabetes among adults are West Virginia, Mississippi, and Louisiana, while Utah and Colorado report the lowest rates. In West Virginia, around ** percent of adults have been diagnosed with diabetes.

United States US: Diabetes Prevalence: % of Population Aged 20-79 data was reported at 10.790 % in 2017. United States US: Diabetes Prevalence: % of Population Aged 20-79 data is updated yearly, averaging 10.790 % from Dec 2017 (Median) to 2017, with 1 observations. United States US: Diabetes Prevalence: % of Population Aged 20-79 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Diabetes prevalence refers to the percentage of people ages 20-79 who have type 1 or type 2 diabetes.; ; International Diabetes Federation, Diabetes Atlas.; Weighted average;

Health, United States is an annual report on trends in health statistics, find more information at http://www.cdc.gov/nchs/hus.htm.

Diabetes prevalence (% of population ages 20 to 79) in United States was reported at 13.7 % in 2024, according to the World Bank collection of development indicators, compiled from officially recognized sources. United States - Diabetes prevalence (% of population ages 20 to 79) - actual values, historical data, forecasts and projections were sourced from the World Bank on October of 2025.

This is a source dataset for a Let's Get Healthy California indicator at "https://letsgethealthy.ca.gov/. This table displays the prevalence of diabetes in California. It contains data for California only. The data are from the California Behavioral Risk Factor Surveillance Survey (BRFSS). The California BRFSS is an annual cross-sectional health-related telephone survey that collects data about California residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services. The BRFSS is conducted by Public Health Survey Research Program of California State University, Sacramento under contract from CDPH. This prevalence rate does not include pre-diabetes, or gestational diabetes. This is based on the question: "Has a doctor, or nurse or other health professional ever told you that you have diabetes?" The sample size for 2014 was 8,832. NOTE: Denominator data and weighting was taken from the California Department of Finance, not U.S. Census. Values may therefore differ from what has been published in the national BRFSS data tables by the Centers for Disease Control and Prevention (CDC) or other federal agencies.

In 2023, almost 14 percent of all women in Mississippi had been diagnosed with diabetes. This statistic displays rates of diagnosed diabetes among women in the U.S. in 2023.

This dataset provides diabetes prevalence estimates by county and sex for the prevalence of diagnosed, undiagnosed, and total diabetes, as well as rates of diagnosis and effective treatment for 1999-2012. The dataset contains estimates for all states and counties, the District of Columbia, and the United States as a whole.

This data package contains dataset on prevalence rates of health conditions and diseases like obesity, diabetes and hearing loss and health risk factors for diseases like tobacco, alcohol and drug use.

This dataset tracks the updates made on the dataset "Selected Trend Table from Health, United States, 2011. Diabetes prevalence and glycemic control among adults 20 years of age and over, by sex, age, and race and Hispanic origin: United States, selected years 1988 - 1994 through 2003 - 2006" as a repository for previous versions of the data and metadata.

This forecast represents the prevalence of diabtes among the total population of the United States in 2025, sorted by characteristic. In 2025, the diabetes prevalence for the United States is expected to be **** percent.

Comprehensive dataset containing 36 verified American Diabetes Association locations in United States with complete contact information, ratings, reviews, and location data.

In 2023, it was estimated that almost 21 percent of those aged 65 years and older in the United States had been diagnosed with diabetes. This statistic shows the percentage of U.S. adults aged 65 years and older who had ever been told by a doctor or other health professional they had diabetes from 2019 to 2023.

This dataset contains information on the total proportion of adults diagnosed with diabetes, collected from the system of health-related telephone surveys, the Behavioral Risk Factor Surveillance System (BRFSS), conducted in more than 400,000 patients, from 50 states in the US, the District of Columbia and three US territories.

In 2022, there were almost **** million people who were newly diagnosed with diabetes in the United States. This statistic represents the number of new cases of diagnosed diabetes among U.S. adults per year from 2000 to 2022, in thousands of people.

This subset of the community health indicator report data will not be updated. A dataset containing all of the community health indicators is now available. To view the latest community health obesity and diabetes related indicators, see the featured content section. This Obesity and Diabetes Related Indicators dataset provides a subset of data (40 indicators) for the two topics: Obesity and Diabetes. The dataset includes percentage or rate for Cirrhosis/Diabetes and Obesity and Related Indicators, where available, for all counties, regions and state.
New York State Community Health Indicator Reports (CHIRS) were developed in 2012, and annually updated to provide data for over 300 health indicators, organized by 15 health topic and data for all counties, regions and state are presented in table format with links to trend graphs and maps. Most recent county and state level data are provided. Multiple year combined data offers stable estimates for the burden and risk factors for these two health topics.

Comprehensive dataset containing 83 verified Diabetes center businesses in Washington, United States with complete contact information, ratings, reviews, and location data.

The Statewide Planning and Research Cooperative System (SPARCS) Inpatient De-identified dataset contains discharge level detail on patient characteristics, diagnoses, treatments, services, and charges. This data contains basic record level detail regarding the discharge; however the data does not contain protected health information (PHI) under Health Insurance Portability and Accountability Act (HIPAA). The health information is not individually identifiable; all data elements considered identifiable have been redacted. For example, the direct identifiers regarding a date have the day and month portion of the date removed. A downloadable file with this data is available for ease of download at: https://health.data.ny.gov/Health/Hospital-Inpatient-Discharges-SPARCS-De-Identified/3m9u-ws8e. For more information check out: http://www.health.ny.gov/statistics/sparcs/ or go to the “About” tab.

This map was developed by the University of New Mexico Prevention Research Center in partnership with the Step Into Cuba Alliance and New Mexico Community Data Collaborative. For more information about this map, please contact Andrea Cantarero (arcantarero@unm.edu).The map displays annual death rates per 100,000 population (age-adjusted) due to chronic disease over the 13 year period from 1999 to 2011. Rates are displayed overall as well as for each race/ethnicity and by sex, for all 109 NM Small Area geographies. Death rates are explored in context of the Village of Cuba proposal to increase access to the Continental Divide Trail to better serve the local community as well as the broader Hwy 550 Corridor population.NEW MEXICO STATE AVERAGESRate per 100,000 of Diabetes Deaths: 30.2Rate per 100,000 of Diabetes Deaths, Hispanic: 42.2Rate per 100,000 of Diabetes Deaths, White: 20.3Rate per 100,000 of Diabetes Deaths, Native American: 73.6Rate per 100,000 of Diabetes Deaths, African American: 47.8Rate per 100,000 of Diabetes Deaths, Asian or Pacific Islander: 23.2Diabetes deaths were defined as Diabetes mellitus (ICD10: E10-E14).Data Sources: New Mexico Death Certificate Database, Office of Vital Records and Statistics, New Mexico Department of Health; Population Estimates: University of New Mexico, Geospatial and Population Studies (GPS) Program, http://bber.unm.edu/bber_research_demPop.html. Retrieved Mon, 19 May 2014 from New Mexico Department of Health, Indicator-Based Information System for Public Health Web site: http://ibis.health.state.nm.usNOTES:New Mexico Small Areas are 109 geographic areas across the state with approximately equal population sizes (~20,000) that are just large enough to calculate rates for selected health events. For more information, please visit http://ibis.health.state.nm.us/resources/SmallAreaMethods.html.

The Diabetes Prevention Program (DPP) is a clinical trial that investigated whether modest weight loss through dietary changes and increased physical activity or treatment with the oral diabetes drug metformin (Glucophage) could prevent or delay the onset of type 2 diabetes in high risk individuals with prediabetes.

The study enrolled overweight persons with elevated fasting and post-load plasma glucose concentrations. Participants were randomized to placebo, metformin (850 mg twice daily), or a lifestyle-modification program with the goals of at least a 7 percent weight loss and at least 150 minutes of physical activity per week. The primary outcome measure was development of diabetes, diagnosed on the basis of an annual oral glucose-tolerance test or a semiannual fasting plasma glucose test, according to the 1997 criteria of the American Diabetes Association: a value for plasma glucose of 126 mg per deciliter (7.0 mmol per liter) or higher in the fasting state, or 200 mg per deciliter (11.1 mmol per liter) or higher two hours after a 75-g oral glucose load. Participation in DPP continued after a diagnosis of diabetes was made, although study medication was discontinued and participants were sent to their local primary care provider for treatment of diabetes once fasting glucose was > 140 mg/dl.

Results showed that both lifestyle changes and treatment with metformin reduced the incidence of diabetes in persons at high risk compared with placebo. Furthermore, the lifestyle intervention was more effective than metformin in preventing the onset of diabetes.

Supplemental measurements were collected using biospecimens that were obtained during the original DPP clinical trial. These measurements included antibodies, biomarkers, hormones, and vitamin D levels to assess the relationships between sex hormones, diabetes risk factors, and the progression to diabetes. The supplemental data showed that sex hormones were associated with diabetes risk in men, but these associations were not found in women. Furthermore, obesity and glycemia were more important predictors of diabetes risk than sex hormones.